Related Experiment Videos

Gastric inflammatory myofibroblastic proliferation in children

J Estêvão-Costa1, J Correia-Pinto, F C Rodrigues

  • 1Department of Pediatrics, Faculty of Medicine, University of Porto, Portugal.

Insights

Gastric inflammatory myofibroblastic proliferation (IMP) is a rare pediatric condition. This study details the ninth case, highlighting its presentation, pathology, and benign nature, crucial for avoiding misdiagnosis and aggressive treatment.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Pathology

Background:

  • Gastric inflammatory myofibroblastic proliferation (IMP) is exceptionally rare in children, primarily documented in case reports.
  • This review encompasses the ninth pediatric case, detailing etiology, clinical/laboratory findings, pathology, treatment, and outcomes.

Observation:

  • A predilection for preschool-aged females was noted.
  • Key clinical features include abdominal pain, upper gastrointestinal hemorrhage, and abdominal mass.
  • Constant finding of iron-deficiency anemia in affected children.

Findings:

  • Lesions are elevated, full-thickness gastric wall involvements, often with luminal ulceration.
  • Extragastric extension mimicking malignancy is frequent.
  • Histological diagnosis post-surgical excision is definitive; Helicobacter pylori association suggests inflammatory origin.

Implications:

  • Gastric IMP is a benign entity that can be mistaken for malignancy.
  • Surgical excision is curative with low recurrence and no direct mortality.
  • Awareness is vital to prevent unnecessary aggressive therapies in pediatric patients.

Related Concept Videos